Relapsing Reiter's syndrome after Bacillus Calmette-Guérin immunotherapy for bladder carcinoma [2];Síndrome de Reiter recidivante después de inmunoterapia con Bacillus Calmette-Guérin para el carcinoma de vejiga

Medicina Clinica

Volumn 121, Issue 9, 2003, Pages 356-357

  Pego, José María ^a   Lamas, Cipriano ^a   Hernández, Iñigo ^a   Suso, Javier ^a  

^a HOSPITAL DO MEIXOEIRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BCG VACCINE; INDOMETACIN; PREDNISONE; TRIAMCINOLONE ACETONIDE;

ADULT; ANAMNESIS; ARTHROCENTESIS; BIOCHEMISTRY; BLADDER CARCINOMA; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CARCINOMA IN SITU; CASE REPORT; CLINICAL FEATURE; CONJUNCTIVITIS; HUMAN; LABORATORY TEST; LETTER; MALE; REITER SYNDROME; RELAPSE; REMISSION; SEDIMENTATION RATE; SYNOVIAL FLUID;

EID: 0142062410     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13050828     Document Type: Letter

References (10)

1. Lamm DL, Stogdill VD, Stogdill BJ, Crispen RG. Complications of Bacillus Calmette-Guérin immunotherapy in 1278 patients with bladder cancer. J Urol 1986;135:272-4.
2. De Torres JA, Lorente JA, Villegas G, Lience E. Poliartritis como complicación del tratamiento con BCG intravesical. Med Clin (Barc) 1993; 30:158-9.
3. Bast RC Jr, Zbar B, Borsos T, Rapp HJ. BCG and cancer. N Engl J Med 1974;290:1413-20.
4. Prescott S, Jackson AM, Hawkyard SJ, Alexandroff AB, James K. Mechanisms of action of intravesical Bacillus Calmette-Guérin: local immune mechanisms. Clin Infect Dis 2000; 31(Suppl 3):91-3.
5. Badalament RA, Herr HW, Wong GY, Gnecco C, Pinsky CM, Whitmore WF Jr, et al. A prospective randomized trial of maintenance versus nonmanteinance intravesical Bacillus Calmette-Guérin therapy of superficial bladder cancer. J Clin Oncol 1987;5:441-9.
6. Faus S, Martínez Montauti JM, Puig L. Reiter's syndrome after administration of intravesical Bacillus Calmette-Guérin. Clin Infect Dis 1993;17:526-7.
7. Nesher G. Reiter syndrome after intravesical BCG therapy. Rev Rhum Ed Fr 1993;60:941.
8. Pancaldi P, Van Linthudt D, Alborino D, Haefliger JM, Ott H. Reiter's syndrome after intravesical Bacillus Calmette-Guérin treatment for superficial bladder carcinoma. Br J Rheumatol 1993;32:1096-8.
9. Prescott S, James K, Hargreave TB, Chisholm GD, Smyth JF. Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. J Urol 1992;147:1636-42.
10. Shoenfeld Y, Aron-Maor A, Tanai A, Ehrenfeld M. BCG and autoimmunity: another two-edged sword. J Autoimmun 2001;16:235-40.